Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that a meeting of our Board of Directors of the Company will be held on Saturday, November 13, 2021, inter alia, to consider and approve Unaudited Stand-alone and Consolidated Financial Results of the Company for the quarter / half year ended September 30, 2021.
|